•
Sep 30, 2023

REGENXBIO Q3 2023 Earnings Report

Total Revenue
$28.9M
Previous year: $26.5M
+9.1%
EPS
-$1.41
Previous year: -$1.75
-19.4%
Gross Profit
$16.5M
Previous year: $13.4M
+23.2%
Cash and Equivalents
$302M
Previous year: $119M
+154.7%
Free Cash Flow
-$50.8M
Previous year: -$55.5M
-8.4%
Total Assets
$634M
Previous year: $884M
-28.3%

REGENXBIO

REGENXBIO